QCOM vs RYTM · P/E 16, rev $44.28B vs rev $130.1M
Qualcomm Incorporated (QCOM) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
QCOM currently screens at market cap $175.02B and trailing P/E 16.3. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the QCOM and RYTM stock pages for the full models.
Not investment advice.